Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by earnings, at CHF 22.6B, ahead of Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B). Figures as of 18 Nov 2026, 19:03 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonCHF 22.6B
- Median
- CHF 49.8M
- Combined market value
- CHF 4.28T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CHF 22.6B | CHF 557.7B | CHF 231.68 | 1.45% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | CHF 17.4B | CHF 1.04T | CHF 1,172.07 | 1.84% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | CHF 15.4B | CHF 287B | CHF 116.43 | 3.72% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | CHF 12.8B | CHF 146.8B | CHF 33.30 | 3.00% down | 17% down | ||
| 5 | NovartisNVS · Health Care | CHF 11.8B | CHF 248.2B | CHF 131.40 | 2.11% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | CHF 8.6B | CHF 234.5B | CHF 151.23 | 1.64% down | 2% up | ||
| 7 | SanofiSNY · Health Care | CHF 7.3B | CHF 95.7B | CHF 39.86 | 0.59% down | 4% down | ||
| 8 | PfizerPFE · Health Care | CHF 6.6B | CHF 135.1B | CHF 23.71 | 1.28% down | 14% up | ||
| 9 | GSKGSK · Health Care | CHF 6.4B | CHF 82.3B | CHF 41.08 | 1.10% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | CHF 6B | CHF 103.4B | CHF 50.60 | 2.22% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | CHF 5.5B | CHF 152.6B | CHF 88.12 | 0.23% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | CHF 3.8B | CHF 82.6B | CHF 798.31 | 1.19% down | 36% up | ||
| 13 | AbbVieABBV · Health Care | CHF 3.6B | CHF 427.8B | CHF 242.01 | 2.02% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | CHF 3.3B | CHF 115.2B | CHF 454.25 | 0.80% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | CHF 2.3B | CHF 29.2B | CHF 71.89 | 2.08% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 1.2B | CHF 41.4B | CHF 35.52 | 1.20% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | CHF 1.1B | CHF 20.9B | CHF 490.90 | 0.37% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | CHF 812.3M | CHF 26.8B | CHF 43.40 | 0.98% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | CHF 650.3M | CHF 33.7B | CHF 58.54 | 1.05% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | CHF 575.8M | CHF 4.2B | CHF 50.82 | 0.18% down | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 384.6M | CHF 10.6B | CHF 12.67 | 1.56% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | CHF 377.2M | CHF 8.4B | CHF 55.71 | 5.32% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | CHF 376.2M | CHF 4.8B | CHF 7.12 | 2.14% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | CHF 294.3M | CHF 9.9B | CHF 51.14 | 3.61% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | CHF 264.7M | CHF 17B | CHF 126.60 | 4.10% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | CHF 242M | CHF 39B | CHF 341.52 | 2.03% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | CHF 203.9M | CHF 6.6B | CHF 39.44 | 2.88% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | CHF 105M | CHF 5.1B | CHF 254.28 | 2.60% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | CHF 84.1M | CHF 6.3B | CHF 57.25 | 3.14% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | CHF 60.8M | CHF 6.5B | CHF 18.58 | 4.31% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 49.8M | CHF 6.3B | CHF 80.26 | 0.04% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -CHF 1.4M | CHF 5.2B | CHF 36.59 | 0.90% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -CHF 19.7M | CHF 5.1B | CHF 77.70 | 0.17% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -CHF 21.5M | CHF 4.1B | CHF 43.03 | 0.18% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -CHF 59M | CHF 4.4B | CHF 105.01 | 0.92% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -CHF 65.5M | CHF 5.4B | CHF 133.03 | 0.01% down | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -CHF 88.9M | CHF 5.5B | CHF 80.83 | 0.52% down | 241% up | ||
| 38 | ErascaERAS · Health Care | -CHF 105.1M | CHF 4B | CHF 11.28 | 3.74% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -CHF 109.8M | CHF 6.9B | CHF 106.11 | 0.90% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -CHF 130.9M | CHF 7.7B | CHF 81.50 | 3.00% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -CHF 136.9M | CHF 4.1B | CHF 73.30 | 0.10% down | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -CHF 141.5M | CHF 3.8B | CHF 35.09 | 1.05% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -CHF 154.5M | CHF 6B | CHF 113.38 | 1.13% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -CHF 155M | CHF 3.3B | CHF 24.19 | 2.38% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -CHF 165.8M | CHF 7.1B | CHF 102.09 | 3.78% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -CHF 195.7M | CHF 11.3B | CHF 22.66 | 3.91% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -CHF 213.4M | CHF 15B | CHF 228.55 | 0.09% down | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -CHF 243.2M | CHF 7.9B | CHF 340.69 | 4.29% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -CHF 250.4M | CHF 2.7B | CHF 13.67 | 0.56% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -CHF 252.9M | CHF 23.5B | CHF 32.48 | 0.52% down | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -CHF 255.8M | CHF 7.2B | CHF 258.66 | 0.52% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -CHF 277.5M | CHF 4.1B | CHF 23.58 | 0.38% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -CHF 300.4M | CHF 13.4B | CHF 208.12 | 2.50% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -CHF 314.6M | CHF 6.2B | CHF 70.67 | 2.05% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -CHF 321.7M | CHF 3.9B | CHF 23.59 | 3.71% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -CHF 618.3M | CHF 12.8B | CHF 65.77 | 1.52% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -CHF 662.1M | CHF 6B | CHF 43.36 | 0.48% down | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -CHF 805.1M | CHF 57.6B | CHF 18.02 | 1.27% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -CHF 910.7M | CHF 7.1B | CHF 8.89 | 1.22% down | 36% down | ||
| 60 | InsmedINSM · Health Care | -CHF 1.1B | CHF 22.3B | CHF 101.67 | 1.10% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -CHF 3B | CHF 20B | CHF 17.47 | 1.27% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8435 CHF).
Questions and answers
Which pharmaceutical companies rank first by earnings?
Johnson & Johnson (CHF 22.6B), Eli Lilly (CHF 17.4B) and Merck & Co (CHF 15.4B) are the top three of the 61 pharmaceutical companies ranked by earnings as of 18 Nov 2026, 19:03 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of CHF 4.28T as of 18 Nov 2026, 19:03 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.